NASDAQ
E-therapeutics Plc (ETXPF) has a current ratio of 17.26x as of Monday, May 25, 2026. This represents a 16.27% decrease compared to its 12-month average of 20.61x. The current ratio measures a company's ability to cover short-term obligations by comparing current assets to current liabilities.
No price data available for this timeframe.